858 Therapeutics Raises $50M in Series B Financing - finsmes.com
Sep 27, 2024 · 858 Therapeutics, a San Diego, CA-based biotechnology and drug discovery company, raised $50M in Series B funding.. The round was led by Avidity Partners with …
OFF
858 Therapeutics Raises $50M In Series B Financing - Finsmes.com
6 days from now
Sep 27, 2024 · 858 Therapeutics, a San Diego, CA-based biotechnology and drug discovery company, raised $50M in Series B funding.. The round was led by Avidity Partners with …
finsmes.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · SAN DIEGO--(BUSINESS WIRE)--858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight …
businesswire.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 27, 2024 · “The Series B financing is a testament to the 858 team and the progress we’ve made across our portfolio, including the advancement of our PARG inhibitor ETX-19477 into …
biospace.com
OFF
858 Therapeutics Announces $50 Million Series B Financing
6 days from now
Sep 26, 2024 · SAN DIEGO — 858 Therapeutics today announced it raised $50 million in a Series B financing led by Avidity Partners with participation from Insight Partners, Mirae Asset …
financialpost.com
OFF
858 Therapeutics Secures $50M Series B Financing To Advance …
6 days from now
Oct 3, 2024 · 858 Therapeutics raises $50M in Series B financing led by Avidity Partners. Proceeds to advance ETX-19477, a selective PARG inhibitor for cancer treatment. Phase 1 …
sliceofhealthcare.com
OFF
858 Therapeutics Raises $50 Million In Series B Funding To …
6 days from now
Sep 26, 2024 · 858 Therapeutics has secured $50 million in a Series B funding round led by Avidity Partners, with participation from Insight Partners, Mirae Asset Capital, and Alexandria …
siliconvalleyjournals.com
OFF
858 Therapeutics Secures $50M In Series B Round For Innovations
6 days from now
Sep 26, 2024 · In a significant stride towards advancing its ongoing projects, 858 Therapeutics has successfully secured $50 million in a Series B financing round. This financing, led by …
investorshangout.com
OFF
858 Therapeutics Raises $50M In Series B Financing Round
6 days from now
Sep 27, 2024 · Funds will be used to advance a Phase I trial of 858's PARG inhibitor ETX-19477 in advanced ... 858 Therapeutics Raises $50M in Series B Financing Round ... NEW YORK – …
precisionmedicineonline.com
OFF
858 Therapeutics: Drug Discovery Company Raises $50 Million …
6 days from now
Sep 28, 2024 · 858 Therapeutics announced it raised $50 million in a Series B financing led by Avidity Partners. Participation came from Insight Partners, Mirae Asset Capital, and Alexandria …
pulse2.com
OFF
858 Therapeutics Raises $50M In Series B Financing
6 days from now
Sep 27, 2024 · 858 Therapeutics a start-up biotechnology and drug discovery company based in San Diego has closed Series B worth $50 million. This round was sponsored by Avidity …
growwseed.com
OFF
858 Therapeutics Secures $50 Million In Series B Funding To …
6 days from now
858 Therapeutics, an innovative biotechnology and drug discovery company specializing in oncology, has successfully raised $50 million in its latest funding round. This significant capital …
leadsontrees.com
OFF
Founder Lodge | 858 Therapeutics Raises $50,000,000 At Series B …
6 days from now
Sep 27, 2024 · Series B; $50,000,000 ; 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in …
founderlodge.com
OFF
Series B - 858 Therapeutics - 2024-09-26 - Crunchbase
6 days from now
858 Therapeutics raised $50000000 on 2024-09-26 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. ... $50M. Lead Investors. ... Venture Capital Access Online — 858 …
crunchbase.com
OFF
Ratio Therapeutics Raises $50M In Series B Financing - FinSMEs
6 days from now
Jan 19, 2024 · Ratio Therapeutics, a Boston, MA-based pharmaceutical company, raised $50M in Series B funding.. The round, which brought the total amount to $90M, was led by …
finsmes.com
OFF
858 Therapeutics’ $50 Million Series B Financing
6 days from now
Oct 4, 2024 · 858 Therapeutics’ $50 Million Series B Financing; 858 Therapeutics’ $50 Million Series B Financing. October 4, 2024 Leila Ahmed. Tagged: 10-4-2024 858 Therapeutics Ingo …
globallegalchronicle.com
OFF
Iambic Therapeutics Raises $50M In Series B Extension Funding
6 days from now
Jun 19, 2024 · Iambic Therapeutics, a San Diego, CA-based clinical-stage biotechnology company, raised $50M in Series B extension funding.. The round was led by Mubadala Capital …
finsmes.com
OFF
Zucara Therapeutics Raises US$20M In Series B Financing
6 days from now
Nov 12, 2024 · Zucara Therapeutics, a Toronto, Canada-based diabetes life sciences company, raised US$20M in Series B funding.. The round was led by Sanofi (As part of the agreement, …
finsmes.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
